Works matching IS 00070920 AND DT 2012 AND VI 107 AND IP 11

Results: 20

VeriStrat(®) has prognostic value in advanced stage NSCLC patients treated with erlotinib and sorafenib.

Published in:

2012

By:

Kuiper JL;
Lind JS;
Groen HJ;
Roder J;
Grigorieva J;
Roder H;
Dingemans AM;
Smit EF;
Kuiper, J L;
Lind, J S W;
Groen, H J M;
Roder, J;
Grigorieva, J;
Roder, H;
Dingemans, A M C;
Smit, E F

Publication type:

journal article

Association of creatine kinase and skin toxicity in phase I trials of anticancer agents.

Published in:

British Journal of Cancer, 2012, v. 107, n. 11, p. 1797, doi. 10.1038/bjc.2012.482

By:

Moreno Garcia, V;
Thavasu, P;
Blanco Codesido, M;
Molife, L R;
Vitfell Pedersen, J;
Puglisi, M;
Basu, B;
Shah, K;
Iqbal, J;
de Bono, J S;
Kaye, S B;
Banerji, U

Publication type:

Article

Efficacy of adjuvant aromatase inhibitor in hormone receptor-positive postmenopausal breast cancer patients according to the body mass index.

Published in:

British Journal of Cancer, 2012, v. 107, n. 11, p. 1815, doi. 10.1038/bjc.2012.473

By:

Sendur, M A N;
Aksoy, S;
Zengin, N;
Altundag, K

Publication type:

Article

Anti-tumour activity of two novel compounds in cisplatin-resistant testicular germ cell cancer.

Published in:

British Journal of Cancer, 2012, v. 107, n. 11, p. 1853, doi. 10.1038/bjc.2012.481

By:

Nitzsche, B;
Gloesenkamp, C;
Schrader, M;
Hoffmann, B;
Zengerling, F;
Balabanov, S;
Honecker, F;
Höpfner, M

Publication type:

Article

VeriStrat<sup>®</sup> has prognostic value in advanced stage NSCLC patients treated with erlotinib and sorafenib.

Published in:

British Journal of Cancer, 2012, v. 107, n. 11, p. 1820, doi. 10.1038/bjc.2012.470

By:

Kuiper, J L;
Lind, J S W;
Groen, H J M;
Roder, J;
Grigorieva, J;
Roder, H;
Dingemans, A M C;
Smit, E F

Publication type:

Article

Association of transcobalamin c. 776C>G with overall survival in patients with primary central nervous system lymphoma.

Published in:

2012

By:

Linnebank M;
Moskau S;
Kowoll A;
Semmler A;
Bangard C;
Vogt-Schaden M;
Egerer G;
Schackert G;
Reichmann H;
Schmidt-Wolf IG;
Pels H;
Schlegel U;
Linnebank, M;
Moskau, S;
Kowoll, A;
Semmler, A;
Bangard, C;
Vogt-Schaden, M;
Egerer, G;
Schackert, G

Publication type:

journal article

Sperm counts and endocrinological markers of spermatogenesis in long-term survivors of testicular cancer.

Published in:

British Journal of Cancer, 2012, v. 107, n. 11, p. 1833, doi. 10.1038/bjc.2012.471

By:

Brydøy, M;
Fosså, S D;
Klepp, O;
Bremnes, R M;
Wist, E A;
Bjøro, T;
Wentzel-Larsen, T;
Dahl, O

Publication type:

Article

Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counselling.

Published in:

British Journal of Cancer, 2012, v. 107, n. 11, p. 1826, doi. 10.1038/bjc.2012.464

By:

Xylinas, E;
Cha, E K;
Sun, M;
Rink, M;
Trinh, Q-D;
Novara, G;
Green, D A;
Pycha, A;
Fradet, Y;
Daneshmand, S;
Svatek, R S;
Fritsche, H-M;
Kassouf, W;
Scherr, D S;
Faison, T;
Crivelli, J J;
Tagawa, S T;
Zerbib, M;
Karakiewicz, P I;
Shariat, S F

Publication type:

Article

Association of transcobalamin c. 776C>G with overall survival in patients with primary central nervous system lymphoma.

Published in:

British Journal of Cancer, 2012, v. 107, n. 11, p. 1840, doi. 10.1038/bjc.2012.476

By:

Linnebank, M;
Moskau, S;
Kowoll, A;
Semmler, A;
Bangard, C;
Vogt-Schaden, M;
Egerer, G;
Schackert, G;
Reichmann, H;
Schmidt-Wolf, I G H;
Pels, H;
Schlegel, U

Publication type:

Article

Thymosin beta 15A (TMSB15A) is a predictor of chemotherapy response in triple-negative breast cancer.

Published in:

British Journal of Cancer, 2012, v. 107, n. 11, p. 1892, doi. 10.1038/bjc.2012.475

By:

Darb-Esfahani, S;
Kronenwett, R;
von Minckwitz, G;
Denkert, C;
Gehrmann, M;
Rody, A;
Budczies, J;
Brase, J C;
Mehta, M K;
Bojar, H;
Ataseven, B;
Karn, T;
Weiss, E;
Zahm, D M;
Khandan, F;
Dietel, M;
Loibl, S

Publication type:

Article

EGFR and K-ras gene mutation status in squamous cell anal carcinoma: a role for concurrent radiation and EGFR inhibitors?

Published in:

British Journal of Cancer, 2012, v. 107, n. 11, p. 1864, doi. 10.1038/bjc.2012.479

By:

Paliga, A;
Onerheim, R;
Gologan, A;
Chong, G;
Spatz, A;
Niazi, T;
Garant, A;
Macheto, D;
Alcindor, T;
Vuong, T

Publication type:

Article

VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2.

Published in:

British Journal of Cancer, 2012, v. 107, n. 11, p. 1869, doi. 10.1038/bjc.2012.468

By:

Gavalas, N G;
Tsiatas, M;
Tsitsilonis, O;
Politi, E;
Ioannou, K;
Ziogas, A C;
Rodolakis, A;
Vlahos, G;
Thomakos, N;
Haidopoulos, D;
Terpos, E;
Antsaklis, A;
Dimopoulos, M A;
Bamias, A

Publication type:

Article

Smaller sample sizes for phase II trials based on exact tests with actual error rates by trading-off their nominal levels of significance and power.

Published in:

British Journal of Cancer, 2012, v. 107, n. 11, p. 1801, doi. 10.1038/bjc.2012.444

By:

Khan, I;
Sarker, S-J;
Hackshaw, A

Publication type:

Article

Influence of comorbidity on the effect of adjuvant treatment and age in patients with early-stage breast cancer.

Published in:

British Journal of Cancer, 2012, v. 107, n. 11, p. 1901, doi. 10.1038/bjc.2012.472

By:

Land, L H;
Dalton, S O;
Jensen, M-B;
Ewertz, M

Publication type:

Article

Treatment outcomes for 618 women with gestational trophoblastic tumours following a molar pregnancy at the Charing Cross Hospital, 2000-2009.

Published in:

British Journal of Cancer, 2012, v. 107, n. 11, p. 1810, doi. 10.1038/bjc.2012.462

By:

Sita-Lumsden, A;
Short, D;
Lindsay, I;
Sebire, N J;
Adjogatse, D;
Seckl, M J;
Savage, P M

Publication type:

Article

Calprotectin: a novel biomarker for the diagnosis of pleural effusion.

Published in:

British Journal of Cancer, 2012, v. 107, n. 11, p. 1876, doi. 10.1038/bjc.2012.478

By:

Sánchez-Otero, N;
Blanco-Prieto, S;
Páez de la Cadena, M;
Vázquez-Iglesias, L;
Fernández-Villar, A;
Botana-Rial, M I;
Rodríguez-Berrocal, F J

Publication type:

Article

Ethnicity in relation to incidence of oesophageal and gastric cancer in England.

Published in:

British Journal of Cancer, 2012, v. 107, n. 11, p. 1908, doi. 10.1038/bjc.2012.465

By:

Coupland, V H;
Lagergren, J;
Konfortion, J;
Allum, W;
Mendall, M A;
Hardwick, R H;
Linklater, K M;
Møller, H;
Jack, R H

Publication type:

Article

Differential downregulation of telomerase activity by bortezomib in multiple myeloma cells-multiple regulatory pathways in vitro and ex vivo.

Published in:

British Journal of Cancer, 2012, v. 107, n. 11, p. 1844, doi. 10.1038/bjc.2012.460

By:

Weiss, C;
Uziel, O;
Wolach, O;
Nordenberg, J;
Beery, E;
Bulvick, S;
Kanfer, G;
Cohen, O;
Ram, R;
Bakhanashvili, M;
Magen-Nativ, H;
Shilo, N;
Lahav, M

Publication type:

Article

Serum apolipoprotein C-II is prognostic for survival after pancreatic resection for adenocarcinoma.

Published in:

British Journal of Cancer, 2012, v. 107, n. 11, p. 1883, doi. 10.1038/bjc.2012.458

By:

Xue, A;
Chang, J W;
Chung, L;
Samra, J;
Hugh, T;
Gill, A;
Butturini, G;
Baxter, R C;
Smith, R C

Publication type:

Article

Hypertensive diseases in pregnancy and subsequent lower risk of breast cancer: the common immune and antiangiogenic profile.

Published in:

British Journal of Cancer, 2012, v. 107, n. 11, p. 1915, doi. 10.1038/bjc.2012.487

By:

Carbillon, L

Publication type:

Article